In a recent announcement, former President Donald Trump renewed threats of tariffs on Indian pharmaceutical imports, marking a sudden shift that has negatively impacted Indian pharma stocks. Investors reacted swiftly, reversing the brief respite enjoyed by the sector.
A recent investigation by BBC reveals that an Indian pharmaceutical company is significantly contributing to West Africa’s escalating opioid crisis. The report highlights alarming practices, including the production and distribution of potent opioids, raising concerns about public health and regulatory oversight in the region.
